Volume 70, Issue 4, Pages (October 2016)

Slides:



Advertisements
Similar presentations
PTEN differentially regulates expressions of ICAM-1 and VCAM-1 through PI3K/Akt/GSK-3β/GATA-6 signaling pathways in TNF-α-activated human endothelial.
Advertisements

Volume 11, Issue 4, Pages (April 2007)
Volume 76, Issue 9, Pages (November 2009)
Volume 70, Issue 4, Pages (October 2016)
Volume 131, Issue 4, Pages (October 2006)
Chung S. Lim, MRCS, PhD, Serafim Kiriakidis, PhD, Ewa M
MicroRNA-558 regulates the expression of cyclooxygenase-2 and IL-1β-induced catabolic effects in human articular chondrocytes  S.J. Park, E.J. Cheon,
Volume 130, Issue 3, Pages (March 2006)
Chung S. Lim, MRCS, PhD, Serafim Kiriakidis, PhD, Ewa M
Jinke Cheng, Xunlei Kang, Sui Zhang, Edward T.H. Yeh  Cell 
Crucial Roles of MZF1 and Sp1 in the Transcriptional Regulation of the Peptidylarginine Deiminase Type I Gene (PADI1) in Human Keratinocytes  Sijun Dong,
Twist-related protein 1 negatively regulated osteoblastic transdifferentiation of human aortic valve interstitial cells by directly inhibiting runt-related.
Yeonsue Jang, Sang H. Jeong, Yoon-Hee Park, Hyun C
Volume 68, Issue 4, Pages (October 2015)
Volume 90, Issue 3, Pages (September 2016)
Role of hypoxia-inducible factor-1 alpha in the regulation of plasminogen activator activity in rat knee joint chondrocytes  G. Zhu, Y. Tang, X. Liang,
Volume 54, Issue 4, Pages (October 2008)
Alleviation of Toxicity Caused by Overactivation of Pparα through Pparα-Inducible miR- 181a2  Yanjie Cheng, Zhuying Wei, Shengsong Xie, You Peng, Yi Yan,
Volume 140, Issue 7, Pages (June 2011)
Volume 19, Issue 2, Pages (February 2017)
Volume 11, Issue 5, Pages (May 2007)
Volume 66, Issue 5, Pages (November 2014)
Specificity protein 1 is pivotal in the skin’s antiviral response
Basic Research in Kidney Cancer
Volume 16, Issue 4, Pages (October 2009)
RNA-Seq and ChIP-Seq Reveal SQSTM1/p62 as a Key Mediator of JunB Suppression of NF-κB-Dependent Inflammation  Xiaoling Zhang, Jane Y. Jin, Joseph Wu,
Volume 131, Issue 4, Pages (October 2006)
IFN-γ Upregulates Expression of the Mouse Complement C1rA Gene in Keratinocytes via IFN-Regulatory Factor-1  Sung June Byun, Ik-Soo Jeon, Hyangkyu Lee,
The interferon regulatory factor ICSBP/IRF-8 in combination with PU
Volume 16, Issue 6, Pages (December 2004)
Sp1 Is Required for Glucose-Induced Transcriptional Regulation of Mouse Vesicular Glutamate Transporter 2 Gene  Tao Li, Liqun Bai, Jing Li, Suzu Igarashi,
Volume 78, Issue 1, Pages (July 2010)
Volume 66, Issue 4, Pages (October 2004)
C-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD- and BCR-ABL1–positive cells. c-MYC induces the transcription of LIG3 and PARP1 in FLT3/ITD-
Tomoyasu Hattori, Lukasz Stawski, Sashidhar S
Volume 137, Issue 1, Pages (July 2009)
MicroRNA-101 Exerts Tumor-Suppressive Functions in Non-small Cell Lung Cancer through Directly Targeting Enhancer of Zeste Homolog 2  Ji-guang Zhang,
Understanding the Importance of Smart Drugs in Renal Cell Carcinoma
Volume 75, Issue 12, Pages (June 2009)
Volume 76, Issue 9, Pages (November 2009)
Volume 130, Issue 3, Pages (March 2006)
Development of Allele-Specific Therapeutic siRNA for Keratin 5 Mutations in Epidermolysis Bullosa Simplex  Sarah D. Atkinson, Victoria E. McGilligan,
Volume 56, Issue 1, Pages (October 2014)
Epidermal Growth Factor Receptor–Mediated Proliferation of Enterocytes Requires p21waf1/cip1 Expression  George Sheng, Kathryn Q. Bernabe, Jun Guo, Brad.
Functional Modulation of Gene Expression by Ultraconserved Long Non-coding RNA TUC338 during Growth of Human Hepatocellular Carcinoma  Hui-Ju Wen, Michael.
Volume 23, Issue 10, Pages (October 2015)
Robert Schickel, Sun-Mi Park, Andrea E. Murmann, Marcus E. Peter 
Glucose-Induced β-Catenin Acetylation Enhances Wnt Signaling in Cancer
MiR-125b, a MicroRNA Downregulated in Psoriasis, Modulates Keratinocyte Proliferation by Targeting FGFR2  Ning Xu, Petter Brodin, Tianling Wei, Florian.
The effects of doxycycline and micronized purified flavonoid fraction on human vein wall remodeling are not hypoxia-inducible factor pathway-dependent 
Volume 43, Issue 5, Pages (September 2011)
Volume 3, Issue 1, Pages (January 2013)
FOXO3a Is Activated in Response to Hypoxic Stress and Inhibits HIF1-Induced Apoptosis via Regulation of CITED2  Walbert J. Bakker, Isaac S. Harris, Tak.
Keratinocyte growth factor promotes goblet cell differentiation through regulation of goblet cell silencer inhibitor  Dai Iwakiri, Daniel K. Podolsky 
Volume 9, Issue 5, Pages (November 2005)
Volume 3, Issue 2, Pages (February 2006)
Volume 10, Issue 3, Pages (September 2006)
Volume 127, Issue 4, Pages (October 2004)
Inhibition of PAX3 by TGF-β Modulates Melanocyte Viability
Volume 3, Issue 4, Pages (April 2003)
Volume 128, Issue 7, Pages (June 2005)
Negative Regulation of Tumor Suppressor p53 by MicroRNA miR-504
Fan Yang, Huafeng Zhang, Yide Mei, Mian Wu  Molecular Cell 
Volume 24, Issue 10, Pages (October 2016)
Shipra Das, Olga Anczuków, Martin Akerman, Adrian R. Krainer 
Volume 31, Issue 6, Pages (December 2009)
Figure 4. MicroRNA (miR)-195 and miR-497 directly targets CD274
Volume 14, Issue 1, Pages (July 2013)
Pirh2 represses p73-dependent transactivation.
Volume 21, Issue 4, Pages (February 2006)
Presentation transcript:

Volume 70, Issue 4, Pages 623-632 (October 2016) Renal Cell Carcinoma Programmed Death-ligand 1, a New Direct Target of Hypoxia- inducible Factor-2 Alpha, is Regulated by von Hippel–Lindau Gene Mutation Status  Yosra Messai, Sophie Gad, Muhammad Zaeem Noman, Gwenael Le Teuff, Sophie Couve, Bassam Janji, Solenne Florence Kammerer, Nathalie Rioux-Leclerc, Meriem Hasmim, Sophie Ferlicot, Véronique Baud, Arnaud Mejean, David Robert Mole, Stéphane Richard, Alexander M.M. Eggermont, Laurence Albiges, Fathia Mami-Chouaib, Bernard Escudier, Salem Chouaib  European Urology  Volume 70, Issue 4, Pages 623-632 (October 2016) DOI: 10.1016/j.eururo.2015.11.029 Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 1 von Hippel–Lindau mutation status is associated with programmed death-ligand 1 expression in clear cell renal cell carcinomas. Box plots represent the distribution of programmed death-ligand 1 mRNA expression (average fold change) according to von Hippel–Lindau mutation status for the different classifications (A) loss of heterozygosity, (B) number of altered alleles (1 corresponding to 0 and 1 altered allele), and (C) loss of function (LOF) (presence of LOF=0, absence of LOF=1) (n=32). PD-L1=programmed death-ligand 1. European Urology 2016 70, 623-632DOI: (10.1016/j.eururo.2015.11.029) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 2 Differential programmed death-ligand 1 (PD-L1) expression in 786-O cells transfected with different von Hippel–Lindau mutants. (A) PD-L1, carbonic anhydrase-IX and vascular endothelial growth factor expression were evaluated by SYBR Green quantitative real-time polymerase chain reaction. (B) Western blot was performed to show hypoxia-inducible factor-2 alpha, and PD-L1 protein levels. Actin was used as a loading control. (C) 786-O cells were incubated with interferon gamma for 24h. Western blot was performed to show PD-L1 protein levels. Actin was used as a loading control. (D and E) Surface expression levels of PD-L1 and PD-L2 were determined with flow cytometry. Data represents three independent experiments with standard deviation. Statistically significant difference (indicated by asterisks) between wild-type cells and different von Hippel–Lindau mutants are shown. CA-IX=carbonic anhydrase-IX; HIF-2α=hypoxia-inducible factor-2 alpha; IFN-γ; interferon gamma; PD-L1=programmed death-ligand 1; VEGF=vascular endothelial growth factor. * p<0.05. ** p<0.005. *** p<0.0005). European Urology 2016 70, 623-632DOI: (10.1016/j.eururo.2015.11.029) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 3 Hypoxia-inducible factor-2 alpha (HIF-2α) silencing decreased programmed death-ligand (PD-L1) expression in 786-O and A498 cells. 786-O and A498 cells were transfected with two different small interfering RNAs targeting HIF-2α or scrambled control. (A) Expression levels of HIF-2α, carbonic anhydrase-IX, vascular endothelial growth factor, and PD-L1 were evaluated using SYBR Green quantitative real-time polymerase chain reaction. (B and C) Western blot was performed to show HIF-2α and PD-L1 protein levels in 786-O (B) and A498 (C) cells. Actin was used as a loading control. (D and E) Surface expression levels of PD-L1 in 786-O (D) and A498 (E) cells were determined with flow cytometry. Data represents three independent experiments with standard deviation. Statistically significant difference between cells transfected with small interfering RNA targeting scrambled control or HIF-2α are shown. CA-IX=carbonic anhydrase-IX; CT=scrambled control; HIF-2α=hypoxia-inducible factor-2 alpha; IFN-γ; interferon gamma; PD-L1=programmed death-ligand 1; VEGF=vascular endothelial growth factor. * p<0.05. ** p<0.005. *** p<0.0005). European Urology 2016 70, 623-632DOI: (10.1016/j.eururo.2015.11.029) Copyright © 2015 European Association of Urology Terms and Conditions

Fig. 4 Hypoxia-inducible factor-2 (HIF-2) regulates the expression of programmed death-ligand 1 (PD-L1) by binding directly to the hypoxia-response element-4 in the PD-L1 proximal promoter in 786-O cells. (A) Chromatin immunoprecipitation assay was performed on 786-O cells transfected with either small interfering (si)RNA against HIF-2α or scrambled control and on wild-type (WT) cells using anti-HIF-2α antibody followed by SYBR Green quantitative real-time polymerase chain reaction using vascular endothelial growth factor-A and PD-L1 hypoxia response element (HRE) sites. (B) Different HREs in human PD-L1 promoter are shown. (C) 786-O and WT cells were cotransfected with pGL4-hRluc/SV40 vector and pGL3 empty vector, pGL3 HRE-4 or pGL3 HRE-4 MUT vectors. After 48h, Firefly and Renilla luciferase activities were measured using the dual-luciferase reporter assay and the ratio of Firefly:Renilla luciferase was determined. Data represent three independent experiments with standard deviation. Statistically significant difference (indicated by asterisks) are shown. (D) WT (VHL) cells were transfected with a pcDNA3 EV or pcDNA3-HIF-2α (3μg and 5μg). HIF-2α expression was detected with western blot. Actin was used as a loading control. (E) Surface expression levels of PD-L1 were determined using flow cytometry. Data represent three independent experiments with standard deviation. Statistically significant difference between cells transfected with pcDNA3 EV pcDNA3-HIF-2α are shown. (F–H) HIF-1α and HIF-2α regulate PD-L1 expression in RCC4 cell line. RCC4 cells were transfected with siRNAs targeting HIF-1α, HIF-2α, both HIF-1α and HIF-2α or scrambled control. (F) Expression levels of vascular endothelial growth factor and PD-L1 were evaluated by SYBR Green quantitative real-time polymerase chain reaction. (G) Western blot was performed to show HIF-1α, HIF-2α, and PD-L1 protein levels in RCC4. Actin was used as a loading control. (H) Surface expression levels of PD-L1 in RCC4 were determined with flow cytometry. The graph represents percentage of positive cells. Data represent two independent experiments with standard deviation. Statistically significant difference between cells transfected with siRNA targeting scrambled control or HIF-1α, HIF-2α,and HIF-1α + HIF-2α are shown. CA-IX=carbonic anhydrase-IX; CT=scrambled control; HIF-2α=hypoxia-inducible factor-2 alpha; HRE=hypoxia response element; IFN-γ; interferon gamma; IgG=immunoglobulin-G; PD-L1=programmed death-ligand 1; VEGF=vascular endothelial growth factor; WT=wild type. * p<0.05. ** p<0.005. *** p<0.0005). European Urology 2016 70, 623-632DOI: (10.1016/j.eururo.2015.11.029) Copyright © 2015 European Association of Urology Terms and Conditions